News and Updates
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Survey on the added value of MSCA PhDs
The European Research Executive Agency (REA) of the European Commission is conducting a survey to gather (anonymous) feedback on the added value of MSCA PhDs, in comparison to other doctoral programmes.
The survey is addressed to principal investigators/supervisors as well as PhD researchers (PhD completed or ongoing) involved in MSCA and non-MSCA funded projects.
This feedback is highly valuable as it will help to improve the MSCA Doctoral Networks programme, which is managed by the REA. It will also feed into the European Commission’s wider policy reflections for the forthcoming period: promoting excellence in doctoral education and training is relevant to their strategic objectives for both the European Research Area (ERA) and the European Education Area (EEA), and contributes to the implementation of the European Strategy for Universities (here and here) .
The survey can be accessed here and the Data Protection Notice here. Please note that it may take up to 1-2 minutes for the survey to load completely. The survey should take approximately 15 minutes to complete. The survey will remain open until 10 November 2024.
Related News
|
2024-12-06
|
2 weeks ago |
Innonext the Next Generation Innovation Talent’s Initiative call open |
|
2024-10-04
|
2 months ago |
Joint statement ‘We need much more MSCA!’ published |
|
2024-09-27
|
2 months ago |
Number of submitted proposals MSCA Cofund 2024 call |
|
2024-09-20
|
3 months ago |
Marie Skłodowska-Curie Actions’ Newsletter latest edition |
|
2024-09-12
|
3 months ago |
Number of submitted proposals - MSCA Postdoctoral Fellowships 2024 call – deadline 11... |
|
2024-09-02
|
3 months ago |
Horizon Europe Impact training session and Proposal workshop coming up this Autumn |
|
2024-08-23
|
4 months ago |
Apply now to attend the 74th Lindau meeting on chemistry |
|
2024-07-15
|
5 months ago |
MSCA4Ukraine second call for applications: submission platform for host organisations... |
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Latest News
1505 articles available search in articlesSecurity AI, data & cloud Cybersecurity Defence
Call for the Defence-related Research Action (DEFRA) is officially open
The fifth call for proposals of the Defence-related Research Action (DEFRA) is officially open. All information is available on the DEFRA website. Pre-proposals can be submitted via the online submission platform. Deadline is Deadline is 20 February 2025, 14h. We recommend you start preparing your proposal on the online submission platform as soo... read more
Horizon Europe Digital Europe Defence
Happy holidays!
The NCP Flanders team wishes you happy holidays and all the best for 2025! Please note that our offices are closed between Christmas and new year. read more
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
